¼¼°èÀÇ ¿ìÁÖ ±â¹Ý ¹ÙÀÌ¿ÀÀǾàǰ ½ÃÀå º¸°í¼­(2025³â)
Space-Based Biopharmaceuticals Global Market Report 2025
»óǰÄÚµå : 1760718
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 175 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,192,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 8,951,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,709,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¿ìÁÖ ±â¹Ý ¹ÙÀÌ¿ÀÀǾàǰ ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³â µ¿¾È ºü¸£°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2029³â¿¡´Â 11.7%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î 74¾ï 6,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ¼ºÀåÀº »ó¾÷¿ë ¿ìÁÖ »ê¾÷ÀÇ È®´ë, ¿ìÁÖ °ü±¤ÀÇ ºÎ»ó, ¼¼°è Àα¸ÀÇ °í·ÉÈ­, ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ¿ìÁÖ ¿¬±¸¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡¿¡ ÀÇÇØ ÁÖµµµÉ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ¿ø°Ý »ý¹°ÇÐÀû Á¦Á¦ Á¦Á¶, AI ±â¹Ý ½ÇÇè ¼³°è, ¿ø°Ý ÀÇ·á¿Í ¿ìÁÖ ¿¬±¸ÀÇ ÅëÇÕ, ºÐ¼® ÀåºñÀÇ ¼ÒÇüÈ­, ÀÚµ¿ ¿ìÁÖ ½ÇÇè Ç÷§ÆûÀÇ °³¹ß µîÀÌ ÀÖ½À´Ï´Ù.

÷´Ü Ä¡·áÁ¦¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ¿ìÁÖ ±â¹Ý ¹ÙÀÌ¿À ÀǾàǰ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯ÀüÀÚ Ä¡·á, ¼¼Æ÷ Ä¡·á, »ý¹°ÇÐÀû Á¦Á¦¸¦ Æ÷ÇÔÇÑ ÀÌ·¯ÇÑ Â÷¼¼´ë Ä¡·áÁ¦´Â ºÐÀÚ ¶Ç´Â ¼¼Æ÷ ¼öÁØ¿¡¼­ Áúº´À» Ç¥ÀûÀ¸·Î »ï´Â °ÍÀ» ¸ñÇ¥·Î ÇÕ´Ï´Ù. ¾Ï, À¯Àü¼º Áúȯ, ÀÚ°¡¸é¿ªÁúȯ°ú °°Àº º¹ÀâÇÏ°í ¸¸¼ºÀûÀÎ ÁúȯÀÇ À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ±âÁ¸ ¹æ½Äº¸´Ù ´õ °³ÀÎÈ­µÇ°í Ç¥ÀûÈ­µÈ È¿°úÀûÀÎ Ä¡·á¹ýÀÌ ¿ä±¸µÇ¸é¼­ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¿ìÁÖ ±â¹Ý ¹ÙÀÌ¿ÀÀǾàǰÀº ¹Ì¼¼Áß·ÂÀ̶ó´Â µ¶Æ¯ÇÑ È¯°æÀ» ÀÌ¿ëÇÏ¿© ¾àÈ¿¸¦ Çâ»ó½ÃŰ°í º¹ÀâÇÑ »ý¹°ÇÐÀû Á¦Á¦ÀÇ »ý»ê ¼Óµµ¸¦ ³ôÀÓÀ¸·Î½á ÀÌ·¯ÇÑ ¼ö¿ä¸¦ ÃæÁ·½ÃŰ´Â µ¥ ÀÏÁ¶ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 12¿ù ¿µ±¹ÀÇ Ã·´Ü Ä¡·á ¼¾ÅÍ´Â 2021³â¿¡¼­ 2022³â »çÀÌ¿¡ ÷´Ü Ä¡·á¿¡ ´ëÇÑ ÅõÀÚ°¡ 31% Áõ°¡Çß´Ù°í º¸°íÇß½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â ÷´Ü Ä¡·áÁ¦¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡°¡ ¿ìÁÖ ±â¹Ý ¹ÙÀÌ¿À ÀǾàǰ ½ÃÀåÀÇ È®´ë¸¦ ÃËÁøÇϰí ÀÖÀ½À» º¸¿©ÁÝ´Ï´Ù.

¿ìÁÖ ±â¹Ý ¹ÙÀÌ¿À ÀǾàǰ ½ÃÀåÀÇ ±â¾÷µéÀº ÷´Ü ±â¼úÀ» ÅëÇÕÇϱâ À§ÇØ Àü·«Àû Á¦ÈÞ¸¦ ¸Î´Â °æ¿ì°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¦ÈÞ´Â LIFE Pathfinder ¸ðµâ¿¡ ÷´Ü ¹ÙÀÌ¿À ÀǾàǰ ¹× Á¦Á¶ ½Ã¼³À» Á¦°øÇÏ´Â µ¥ ÃÊÁ¡À» ¸ÂÃß°í ÀÖÀ¸¸ç, ¹ÙÀÌ¿À ÀǾàǰ ¿¬±¸ ¹× Á¦Á¶ÀÇ ¾ö°ÝÇÑ ±âÁØÀ» ÃæÁ·Çϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 8¿ù ¹Ì±¹ÀÇ »ó¾÷¿ë ¿ìÁÖ ±â¾÷ ½Ã¿¡¶ó ½ºÆäÀ̽º(Sierra Space)´Â ·¹µå¿ÍÀ̾î(Redwire)¿Í ÆÄÆ®³Ê½ÊÀ» ¸Î°í Àú±Ëµµ(LEO)¿¡¼­ÀÇ »ó¾÷¿ë Á¦¾à ¹× »ý¸í°øÇÐ ¿¬±¸ ¿ª·®À» °³¹ßÇß½À´Ï´Ù. À̹ø Á¦ÈÞ¿¡´Â ½Ã¿¡¶ó½ºÆäÀ̽ºÀÇ LIFE Habitat Ç÷§Æû¿¡ ÅëÇÕµÉ Ã·´Ü »ý¸í°øÇÐ ¹× Á¦Á¶ ±â¼ú Á¦°øÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ ±â¼ú¿¡´Â °íºÐÀÚ °áÁ¤È­ Àåºñ, »ê¾÷¿ë °áÁ¤ Á¦Á¶ Àåºñ, ¿Âµµ ±¸¹è·Î µîÀÌ Æ÷ÇԵǸç, ¸ðµÎ ¹Ì¼¼Áß·Â ÇÏ¿¡¼­ ÀǾàǰ °³¹ß ¹× ÀÎü °Ç°­ ¿¬±¸¸¦ Áö¿øÇÏ´Â °ÍÀ» ¸ñÇ¥·Î ÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ¹«¿ª ÀüÀï°ú °ü¼¼, ±×¸®°í ÄڷγªÀç³­°ú ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°/±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀå ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Space-based biopharmaceuticals are drugs and biologics that are developed or produced in the unique conditions of space, especially microgravity. These conditions can improve processes such as protein crystallization and drug stability. The goal is to use space's environment to create more effective treatments and innovative compounds that may not be possible to develop on Earth.

The primary categories of space-based biopharmaceuticals include vaccines, therapeutics, diagnostics, and other related products. Research conducted in space helps create vaccines that are more stable and effective by utilizing microgravity to improve antigen stability, protein crystallization, and immune response modeling. These products are applied in areas such as cancer treatment, infectious diseases, genetic disorders, and various other health conditions. The main users of these products include pharmaceutical companies, research organizations, healthcare providers, and additional stakeholders.

The space-based biopharmaceuticals market research report is one of a series of new reports from The Business Research Company that provides space-based biopharmaceuticals market statistics, including the space-based biopharmaceuticals industry global market size, regional shares, competitors with the space-based biopharmaceuticals market share, detailed space-based biopharmaceuticals market segments, market trends, and opportunities, and any further data you may need to thrive in the space-based biopharmaceuticals industry. This space-based biopharmaceuticals market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The space-based biopharmaceuticals market size has grown rapidly in recent years. It will grow from $4.29 billion in 2024 to $4.80 billion in 2025 at a compound annual growth rate (CAGR) of 11.9%. The growth observed during the historic period can be credited to the rising demand for high-quality biopharmaceuticals, the emergence of private companies in the space sector, increased financial investment in space missions, the development and functionality of space stations, and the expansion of space-based manufacturing.

The space-based biopharmaceuticals market size is expected to see rapid growth in the next few years. It will grow to $7.46 billion in 2029 at a compound annual growth rate (CAGR) of 11.7%. The growth in the forecast period is expected to be driven by the expansion of the commercial space industry, the rise of space tourism, the aging global population, the growing demand for personalized medicine, and increased investment in space research. Key trends for the forecast period include remote biologics manufacturing, AI-driven experiment design, integration of telemedicine with space research, miniaturization of analytical devices, and the development of automated space lab platforms.

The increasing demand for advanced therapeutics is expected to drive the growth of the space-based biopharmaceuticals market. These next-generation treatments, including gene therapy, cell therapy, and biologics, aim to target diseases at the molecular or cellular level. The rising demand is fueled by the growing prevalence of complex and chronic conditions such as cancer, genetic disorders, and autoimmune diseases, which require more personalized, targeted, and effective therapies than traditional methods offer. Space-based biopharmaceuticals help meet this demand by using the unique environment of microgravity to improve drug efficacy and speed up the production of complex biologics. For example, in December 2023, the Advanced Therapy Treatment Centre in the UK reported a 31% increase in investment in advanced therapies between 2021 and 2022. This trend demonstrates how the growing demand for advanced therapeutics is driving the expansion of the space-based biopharmaceuticals market.

Companies in the space-based biopharmaceuticals market are increasingly forming strategic alliances to integrate cutting-edge technology. These collaborations focus on providing advanced biopharma and manufacturing facilities for the LIFE Pathfinder module, which are designed to meet the rigorous standards of biopharmaceutical research and production. For example, in August 2023, Sierra Space, a US-based commercial space company, partnered with Redwire Corporation to develop commercial pharmaceutical and biotech research capabilities in low-Earth orbit (LEO). This partnership also involves providing advanced biotechnology and manufacturing technologies to be incorporated into Sierra Space's LIFE habitat platform. The technologies include equipment for large molecule crystallization, industrial crystal manufacturing, and gradient-temperature furnaces, all aimed at supporting pharmaceutical drug development and human health research in microgravity.

In March 2025, Sierra Space joined forces with Yuri, a Germany-based space biotech company specializing in microgravity research and bioreactor technology. The goal of this partnership is to accelerate medical and biological research in space, facilitating innovative drug discovery and the development of advanced therapeutic solutions for diseases on Earth.

Major players in the space-based biopharmaceuticals market are Merck & Co. Inc., Bristol-Myers Squibb Company, Sierra Space Corporation, Rocket Lab USA Inc., Redwire Corporation, Axiom Space Inc., Varda Space Industries Inc., Nanoracks LLC, ResearchSat Pty Ltd., Techshot Inc., Space Tango Inc., nScrypt Inc., SpacePharma SA, Space Forge Ltd., LambdaVision Inc., Kibo Biotech Platform, ISS National Lab, BioServe Space Technologies, Space LiinTech, BioOrbit.

North America was the largest region in the space-based biopharmaceuticals market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in space-based biopharmaceuticals report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the space-based biopharmaceuticals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The space-based biopharmaceuticals market consists of revenues earned by entities by providing services such as microgravity research, in-space manufacturing, ISS utilization, and biocrystal optimization services. The market value includes the value of related goods sold by the service provider or included within the service offering. The space-based biopharmaceuticals market also consists of sales of products including protein crystals for drug development, artificial retinas, stem cell-based therapies, and drug delivery systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Space-Based Biopharmaceuticals Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on space-based biopharmaceuticals market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for space-based biopharmaceuticals ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The space-based biopharmaceuticals market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Space-Based Biopharmaceuticals Market Characteristics

3. Space-Based Biopharmaceuticals Market Trends And Strategies

4. Space-Based Biopharmaceuticals Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Space-Based Biopharmaceuticals Growth Analysis And Strategic Analysis Framework

6. Space-Based Biopharmaceuticals Market Segmentation

7. Space-Based Biopharmaceuticals Market Regional And Country Analysis

8. Asia-Pacific Space-Based Biopharmaceuticals Market

9. China Space-Based Biopharmaceuticals Market

10. India Space-Based Biopharmaceuticals Market

11. Japan Space-Based Biopharmaceuticals Market

12. Australia Space-Based Biopharmaceuticals Market

13. Indonesia Space-Based Biopharmaceuticals Market

14. South Korea Space-Based Biopharmaceuticals Market

15. Western Europe Space-Based Biopharmaceuticals Market

16. UK Space-Based Biopharmaceuticals Market

17. Germany Space-Based Biopharmaceuticals Market

18. France Space-Based Biopharmaceuticals Market

19. Italy Space-Based Biopharmaceuticals Market

20. Spain Space-Based Biopharmaceuticals Market

21. Eastern Europe Space-Based Biopharmaceuticals Market

22. Russia Space-Based Biopharmaceuticals Market

23. North America Space-Based Biopharmaceuticals Market

24. USA Space-Based Biopharmaceuticals Market

25. Canada Space-Based Biopharmaceuticals Market

26. South America Space-Based Biopharmaceuticals Market

27. Brazil Space-Based Biopharmaceuticals Market

28. Middle East Space-Based Biopharmaceuticals Market

29. Africa Space-Based Biopharmaceuticals Market

30. Space-Based Biopharmaceuticals Market Competitive Landscape And Company Profiles

31. Space-Based Biopharmaceuticals Market Other Major And Innovative Companies

32. Global Space-Based Biopharmaceuticals Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Space-Based Biopharmaceuticals Market

34. Recent Developments In The Space-Based Biopharmaceuticals Market

35. Space-Based Biopharmaceuticals Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â